Edwards Lifesciences Corp (NYSE: EW): Is It A Buying Opportunity Again?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. The stock was recently discussed on Yahoo Finance as it revealed that Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

EW belongs to the Healthcare sector of the NYSE while operating in the Medical Devices industry. The current market capitalization of Edwards Lifesciences Corp is $56.41B. A total of 6.85 million shares were traded on the day, compared to an average of 4.33M shares.

In the most recent transaction, Lippis Daniel J. sold 1,715 shares of EW for 90.98 per share on Mar 07 ’24. After the transaction, the CVP, JAPAC now owns 17,213 company shares. In a previous transaction on Mar 04 ’24, MUSSALLEM MICHAEL A sold 29,350 shares at 86.67 per share. EW shares that Director owns now total 4,486.

Among the insiders who sold shares, Ullem Scott B. disposed of 7,255 shares on Feb 29 ’24 at a per-share price of $85.59. This resulted in the CVP, Chief Financial Officer holding 19,074 shares of EW after the transaction. In another insider transaction, GALLAHUE KIERAN sold 3,058 shares at $87.61 per share on Feb 23 ’24. Company shares held by the Director now total 67,219.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, EW has a high of $94.87 and a low of $60.57.

As of this writing, EW has an earnings estimate of $0.64 per share for the current quarter. EPS was calculated based on a consensus of 24 estimates, with a high estimate of $0.66 per share and a lower estimate of $0.63.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. EW’s latest balance sheet shows that the firm has $1.47B in Cash & Short Term Investments as of fiscal 2021. There were $690.30M in debt and $1.03B in liabilities at the time. Its Book Value Per Share was $11.06, while its Total Shareholder’s Equity was $5.84B.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EW is Buy with a score of 3.76.

Most Popular

Related Posts